Cancellation of remaining publicly held registered shares of Vifor Pharma AG
Retrieved on:
Wednesday, December 14, 2022
53 LR
Key Points:
- 53 LR
Vifor Pharma AG ("Vifor") announced today that the Commercial Court St.Gallen has cancelled (kraftlos erklrt) all remaining publicly held registered shares of Vifor with a nominal value of CHF0.01 each (each a "Vifor Share"). - Vifor further announced today that SIX Exchange Regulation AG has determined the last trading day and the delisting date of the Vifor Shares at and from SIX Swiss Exchange as follows:
As a result of the cancellation of the remaining publicly held Vifor Shares, each holder of cancelled Vifor Shares is entitled to a compensation of USD179.25 in cash per cancelled Vifor Share. - The envisaged settlement date for payment of such compensation against delivery of the cancelled Vifor Shares is 28 December 2022.
- Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care).